Stereotactic body radiation therapy (Sbrt) for a patient with a myocardial metastasis: A case report

2Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Metastatic lesions of the heart are rare but have the potential to cause significant morbidity. We describe the case of a patient with renal cell carcinoma who presented with shortness of breath and palpitations and was found to have a metastatic myocardial lesion causing arrythmia. He received stereotactic body radiation therapy (SBRT) to alleviate symptoms and provide local control. SBRT planning was executed using a four-dimensional computed tomography (4DCT) scan to account for respiratory and cardiac motion. Images from a planning magnetic resonance imaging (MRI) scan and a gated diagnostic MRI scan of the heart were fused with the 4DCT to assist with delineating the tumour. A dose of 30 Gy in five fractions was delivered without incident. The patient’s cardiac MRI at two months post-treatment showed stability of his cardiac lesion. He subsequently died of distant disease progression, without any recurrence of his cardiac symptoms. SBRT may be considered for patients who present with a symptomatic metastatic cardiac lesion.

Cite

CITATION STYLE

APA

Dhar, A., Donovan, E., Leong, D., Hotte, S. J., & Swaminath, A. (2021). Stereotactic body radiation therapy (Sbrt) for a patient with a myocardial metastasis: A case report. Current Oncology, 28(1), 390–395. https://doi.org/10.3390/curroncol28010041

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free